According to iTeos Therapeutics's latest financial reports the company has $0.53 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.53 B | -13.25% |
2022-12-31 | $0.61 B | -27.74% |
2021-12-31 | $0.84 B | 152.3% |
2020-12-31 | $0.33 B | 1592.8% |
2019-12-31 | $19.86 M | -9.64% |
2018-12-31 | $21.98 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -60.86% | ๐บ๐ธ USA |